Send to a Friend Share

Notable 52-Week High's and Low's of the Day 06/30: STST, ABII High; YHOO, MON, SUPG, RIMM Low

June 30, 2010 3:23 PM EDT
This report is a mid-day check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:
  • Argon ST, Inc. (Nasdaq: STST) high of $34.29. Argon is to be acquired by Boeing (NYSE: BA) for $34.50/share. Click here to see the full report.

  • Abraxis BioScience, Inc. (Nasdaq: ABII) high of $74.75. Celgene Corporation (Nasdaq: CELG) announced an agreement to acquire Abraxis in a deal worth $2.9 billion plus future payout. Click here for the full report.


52-Week Low:

  • Yahoo! Inc. (Nasdaq: YHOO) low of $13.80. Yahoo took a solid dip at the open, but bounced back on stronger volume and is down trading marginally down 0.25% currently. The shares have been on an overall downward trend since mid-April, and haven't really see the recovery the the broader market has. Also, over the last three months, has touched $14.60 thrice before finally dipping below the support level today.

  • Monsanto Co. (NYSE: MON) low of $45.30. The company reported a Q3 ongoing EPS of $0.81, 1 cent better than the analyst estimate of $0.80. Revenue for the quarter was $2.96 billion, which compares to the estimate of $3.17 billion. Monsanto also reaffirms: sees FY10 EPS of $2.40 - $2.60.

  • SuperGen Inc. (Nasdaq: SUPG) low of $1.80. Lower today as the company announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen (decitabine) for Injection in elderly patients with acute myeloid leukemia. The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care. Overall survival was the primary endpoint of this study. While Dacogen did not achieve statistically significant superiority over the control arm, a trend was evident.

  • Research In Motion Ltd. (Nasdaq: RIMM) low of $49.19. The shares are currently up 1.19% today, but started low as Goldman Sachs noted that Cisco's (Nasdaq: CSCO) development of a 7" Android-based enterprise tablet may be a threat to the introduction of their own tablet, as the two may be ready for release around the same time.
An new positive intra-day rating from Wedbush has helped stabilize the shares.

You May Also Be Interested In


Related Categories

Special Reports

Related Entities

BRIC

Add Your Comment





Follow StreetInsider.com On Twitter